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Abstract
Background: Imprinted genes are expressed from only one allele in a parent-of-origin dependent manner. Loss of imprinted
(LOI) expression can result in a variety of human disorders and is frequently reported in cancer. Biallelic expression of
imprinted genes in adult blood has been suggested as a useful biomarker and is currently being investigated in colorectal
cancer. In general, the expression profiles of imprinted genes are well characterised during human and mouse fetal
development, but not in human adults.
Methodology/Principal Findings:We investigated quantitative expression of 36 imprinted genes in adult human peripheral
blood leukocytes obtained from healthy individuals. Allelic expression was also investigated in B and T lymphocytes and
myeloid cells. We found that 21 genes were essentially undetectable in adult blood. Only six genes were demonstrably
monoallelic, and most importantly, we found that nine genes were either biallelic or showed variable expression in different
individuals. Separated leukocyte populations showed the same expression patterns as whole blood. Differential methylation
at each of the imprinting control loci analysed was maintained, including regions that contained biallelically expressed
genes. This suggests in some cases methylation has become uncoupled from its role in regulating gene expression.
Conclusions/Significance: We conclude that only a limited set of imprinted genes, including IGF2 and SNRPN,may be useful
for LOI cancer biomarker studies. In addition, blood is not a good tissue to use for the discovery of new imprinted genes.
Finally, lymphocyte DNA methylation status in the adult may not always be a reliable indicator of monoallelic gene
expression.
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Introduction
For the majority of expressed human genes there is both a
maternal and a paternal contribution in the offspring. The
exception to this is the small subset of imprinted genes that are
expressed only from one parental allele or the other. Imprinted
genes are important during human development, as demonstrated
by the severe syndromes caused by a loss of imprinting (LOI), i.e,
the expression of both parental alleles, or the complete loss of
expression. Examples include disorders of restricted growth, as
seen in Silver-Russell syndrome and over-growth in Beckwith-
Wiedemann syndrome, which in most cases result from opposing
imprinting disturbances on chromosome 11p15.5 [1]. Imprinting
is thought to have evolved in placental mammals as an adaptive
mechanism to promote or suppress fetal growth in utero [2]. LOI is
also seen at high levels (30–100%) in malignant cells in at least 16
different human cancers [3]. At present, LOI is considered to be
the most abundant and precocious alteration in cancer [4,5]. LOI
is regarded as a potentially valuable diagnostic tool. Tests based on
analysis in adult blood samples of allelic expression of the
imprinted IGF2 gene in the diagnosis of colorectal cancer have
become the subject of commercial development [6].
Currently there are approximately 47 protein coding and long,
non-coding RNA genes known whose imprinted status in humans
has been verified using parent-of-origin in vivo expression analyses.
In addition, there are a large number of imprinted micro- and
SNO RNA molecules (http://igc.otago.ac.nz/). Recently, several
genome-wide screens have been carried out, revealing a great
many more potentially imprinted transcripts, although these
require validation [7–10]. To date the majority of confirmed
imprinted genes are situated in the genome in clusters. This
genomic organisation allows their expression to be collectively
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regulated by a nearby imprinting control region (ICR) or
differentially methylated region (DMR), which is methylated on
one allele but not the other. This methylation is established in the
germline during gonad development of the previous generation
and controls the allele specific expression [11]. The imprinted
expression of some genes is restricted to specific tissues, and is
either: not expressed at all elsewhere e.g. PHLDA2, whose
expression is limited to the placenta [12]; expressed biallelically
elsewhere e.g. GNAS which in the human is ubiquitously expressed
but imprinted only in the thyroid, ovary and pituitary gland [13];
or expressed from the opposite allele in different tissues e.g. GRB10
which is paternally expressed in brain but maternally expressed in
the placenta [14]. For other genes, imprinted expression is found
in the majority of tissues during fetal development, as in the case of
IGF2, but becomes biallelic in some tissues in the adult [15].
Regulation of this temporal and tissue specificity is likely to be
brought about through transcription factor binding to alternative
promoters and enhancers. Once expression is enabled, imprinting
cluster-specific mechanisms promote or prevent transcription of
individual alleles. This control may include antisense transcription
of non-coding RNAs, allelic histone modification, post-zygotic
DNA methylation, RNA interference and the blocking of
enhancers by repressors of boundary elements/transcription
factors such as CTCF and YY1 [16].
Imprinted gene expression status in the healthy adult human
has for obvious reasons been difficult to characterise. Peripheral
blood leukocytes (PBL) are unique as they provide a practical and
available resource for both genomic and epigenomic human
analyses. Imprinting expression patterns and related mechanisms
in the human have largely been extrapolated from experiments in
the mouse, although it is clear that there are important differences
between the two [11,17]. To fill this knowledge gap, particularly
with the growing importance of LOI as a marker in cancer
diagnostics, this study was designed to investigate genomic
imprinting in adult human PBL, analysing 36 gene transcripts,
including representatives from all of the known human imprinted
cluster loci and several isolated imprinted genes. Expression of the
36 transcripts was quantified in adult PBL and in normal first
trimester placenta, liver and brain. As three of the most important
fetal organs for growth and development, these tissues express key
imprinted genes at high levels [12,18] and are also representative
as sites of tissue-specific expression [19]. To investigate the actual
imprinting status of the genes expressed in adult blood, we
genotyped common expressed single nucleotide polymorphisms
(SNPs) in a cohort of 50 healthy adults and analysed allelic
expression in both whole blood and fractionated cellular sub-
populations. Finally, DNA methylation at ICRs was measured in
order to verify DMR maintenance and potentially identify the
source of any imprinting errors.
Materials and Methods
Ethics Statement
Ethical approval for adult blood and fetal tissue collection was
granted by Hammersmith, Queen Charlotte’s & Chelsea and
Acton Hospitals Research Ethics Committee, Project Registration
Nos: 2001/6029 and 2001/6028, respectively.
Participants
Adult volunteers (n = 50) were randomly selected with a
male:female ratio of approximately 1:1, between the ages of 20
to 50 years old, and included individuals of different ethnicity.
Fetal tissues were obtained from first trimester products of
conception from a normal white European cohort.
Sample preparation
Peripheral blood leukocytes (PBL) were extracted from 15 ml
fresh whole blood using LymphoprepTM (Axis Shield, Norway)
according to the manufacturer’s instructions. Genomic DNA was
purified by standard phenol-chloroform extraction. For lineage-
specific analysis, whole blood was separated into CD3, CD15 and
CD19 positive cell fractions using an autoMACSTM Separator
(Miltenyi Biotech, Surrey UK). Total RNA was extracted using
Trizol (Gibco BRL, Paisley, UK), and treated with TURBO
DNase (Ambion, Cambridgeshire, UK) and DNAse1 (Invitrogen,
Paisley, UK). RNA was randomly primed and reverse-transcribed
using Moloney murine leukemia virus reverse transcriptase
(MMLM RT; Promega, Southampton UK). Parallel control
samples omitting MMLV RT were generated in each case. Adult
bone marrow RNA was purchased from Clontech Laboratories
Inc (CA). KCNQ1OT1 strand specific cDNA was created in the
same way except B-ACTIN reverse and KCNQ1OT1 reverse
primers were used instead of random primers.
Non-quantitative RT-PCR
Cycle profiles for a mixed fetal tissue cDNA sample and a
mixed PBL sample (n = 50) were carried out using non-
quantitative (nq)RT-PCR for all genes and resolved on 1.5%
agarose gels stained with ethidium bromide. Gel quantitation was
performed using Imagemaster VDS 2.0 (Pharmacia Biotech,
Bucks, UK) and amplicon densitometry readings vs cycle plots
generated for each gene (data not shown). Mid log-linear phase
cycle numbers were then used for allelic expression nqRT-PCR
(Table S1).
Quantitative expression of imprinted genes in blood
Total RNA was isolated from two indidvidual adult PBL
samples, second trimester fetal brain, placenta and liver samples
(each pooled from three fetuses) and adult bone marrow (from six
individuals aged 38–59 years). cDNA amplification was quanti-
tated with SYBR green dye using the Applied Biosystems 7500
Fast Real-Time PCR System (Cheshire, UK) for 40 cycles. Delta
CTs (DCTs) were generated in triplicate of each transcript using
GAPDH as an endogenous control. Primer sequences and
conditions are listed in Table S2.
Allelic expression analysis
Genotypes were obtained for expressed genes in 50 individuals
using a minimum of one exonic SNP for each gene either by
digestion or sequencing. Sequences were interrogated using
SequencherTM v4.6 (Gene Codes Corporation, MI) to distinguish
heterozygotes (informative) and homozygotes. Informative samples
were analysed for allelic expression using intron crossing primers
(Table S3). Sense/antisense pairs (KCNQ1/KCNQ1OT1 and
MEST/MESTIT1) were analysed independently by ensuring
antisense transcript amplicons lay wholly within introns of the
sense genes. In addition, the samples informative for KCNQ1OT1
were analysed using strand specific RT-PCR. cDNA was prepared
using only B-ACTIN and KCNQ1OT1 reverse oligonucleotides and
RT-PCR carried out as before. For lineage-specific analysis, whole
blood from three individuals was separated into CD19+ B-
lymphocytes (5% total cell count), CD3+ T-lymphocytes (25%)
and CD15+ myeloid cells (50–70%) using an autoMACSTM
Separator (Miltenyi Biotech, Surrey UK).
No parental genotypes were included so imprinting is inferred
from monoallelic expression in heterozygous individuals. Primer
sequences and conditions for genotyping and allelic expression
analysis are listed in Table S3.
Imprinting in Human Blood
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13556
Analysis of differentially methylated regions
Combined bisulphite and restriction analysis (CoBRA; Xiong
and Laird, 1997) was performed using sodium bisulphite treated
PBL DNA samples (n = 2) and purified using the EZ Gold
Methylation KitTM (ZYMO, Orange, CA). Bisulphite specific
primers (Table S4) for each ICR were used with Hotstar Taq
polymerase (Qiagen, West Sussex, UK) at 45 PCR cycles and
amplicons digested using either Taqa1, Tai1, MboI or BstUI
restriction enzymes (enzymes used for each amplicon shown in
Table S4; New England Biolabs). Differentially methylated
products were resolved on 3–4% agarose gels and stained with
ethidium bromide. For pyrosequencing analysis, each assay
included three to eleven CpGs, 12 individuals were analysed.
Genomic DNA was bisulphite treated using EZ DNA methylation
kit (Zymo Research) and used to generate PCR amplified
templates in a two round PCR. The first round used unique
forward and reverse primers. The reverse primer contains an M13
sequence, which was used to tag the 59 end with biotin prior to
sequencing (specific primers and PCR conditions are available on
request). Pyrosequencing was carried out on PSQ HS 96 System
and PyroMark MD System using Pyro Gold Reagent kits (Biotage,
Uppsala, Sweden). Methylation was quantified using Pyro Q-CpG
Software (Biotage, Uppsala, Sweden) that calculates the ratio of
converted C’s (T’s) to unconverted C’s at each CpG and expresses
this as a percentage methylation. Average methylation across the
DMR regions for all CpGs was calculated. Median and IQR
methylation for different samples were analysed using Prism
Graphpad software.
Results
Analysis of imprinted gene expression levels in adult PBL
In order to study imprinting in adult blood, we first investigated
the mRNA expression levels of 36 gene transcripts by quantitative
(q)RT-PCR (Fig. 1), which was performed in two unrelated
healthy adult individuals. Expression values were based on the
amplified product reaching a gene expression threshold (T)
following a number of PCR cycles (C), normalised (D) to the
expression of an endogenous control (GAPDH). The DCT value
was then used as a measure of relative expression. Gene expression
between the two individuals showed a high level of consistency,
where DCT of each gene for the two individuals differed by two
PCR cycles or less for 81% of the genes analysed. Of these, 50%
had a difference of only one cycle between the two individuals
(Table S1).
Non-quantitative (nq-)RT-PCR was carried out in parallel to
qRT-PCR in order to analyse allelic expression on a pool of the
PBL cDNA from our 50 individuals. NqRT-PCR was able to
generate amplicons that could be reliably analysed by sequencing
when the qRT-PCR DCT for that gene was below nine in the
majority of cases. A DCT value of nine is equivalent to 22DCT of
0.0015, and this is indicated on the graph in Fig. 1 by a dotted line.
A DCT of above nine generally correlated with gene expression
that was too low to be amplified by nqRT-PCR and sequenced.
Three genes were expressed at notably high levels: GNAS,
SNRPN and IGF2R. Another nine genes, KCNQ1, KCNQ1OT1,
NAP1L5, IPW, GNAS EXON 1A, SLC22A18, CDKN1C, MEST
Figure 1. Quantitative expression levels and allelic status of imprinted genes in the PBL of two individuals. (i) Allelic expression of the
transcripts we could detect with non-quantitative RT-PCR is shown, aligned with the genes from bar graph (ii). Red bars represent monoallelic
expression and black bars biallelic expression. Using a maximum of 45 cycles the transcripts we could amplify predominately corresponded to those
which on Q-PCR had a DCT ,9, shown by the dotted line. The grey bars represent transcripts that could not be detected using non-quantitative RT-
PCR methods so could not be assigned an allelic preference. (ii) Gene names are plotted on the x axis, against log(10) 2‘-DCt (DCt = the cycle
number at which transcript level reached threshold, corrected to an endogenous control) on the y, using thresholds defined by the linear phase of
curves generated from the real-time amplification. DCTs for triplicates of each transcript were calculated using a GAPDH endogenous control, thus
log(10) 2‘-DCt of GAPDH =1. (iii) Outline of the position of each gene within the human genome, demonstrating the extent of each imprinting
cluster.
doi:10.1371/journal.pone.0013556.g001
Imprinting in Human Blood
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ISOFORM 2 and PEG10 were expressed at a level decreased by
approximately ten fold relative to the three highly expressed genes,
and the remaining 24 genes decreased by at least 100 fold. In
comparison to PBL, fetal placenta, liver and brain expression
levels were higher both in magnitude and in representative
coverage for 28 of the 36 analysed transcripts. These data indicate
that overall, compared to fetal tissues, imprinted genes are not
highly expressed in adult blood (Fig. S1). There were eight genes
whose expression levels in PBL were comparable to or increased
compared to the other tissues; NAP1L5, PLAGL1 Isoform 2,
IGF2R, SLC22A18, KCNQ1OT1, KCNQ1, IPW, SNRPN, TP73 and
GNAS (Fig. S1).
Analysis of allelic expression status of imprinted genes in
adult PBL
To investigate the actual imprinting status of genes in adult
blood, we genotyped 50 unrelated individuals with respect to
common exonic SNPs present in the 15 transcripts that were
expressed at sufficient levels for detection by sequencing. This
analysis revealed three groups of genes (Fig. 1 and Table 1): Group
1: PLAG1 Isoform 2, IGF2R, MEST Isoform 2 (polymorphic),
KCNQ1 and GNAS were expressed biallelically. Each of these genes
are widely expressed but imprinted only in certain tissues, or are
developmentally regulated, so their biallelic status in PBL was not
surprising; Group 2: PEG10, IGF2, SNRPN, NDN, IPW and GNAS
EXON 1A were expressed monoallelically, which was consistent
with their reported status in human fetal and adult tissues; and
finally Group 3: NAP1L5, INPP5F_V2 (polymorphic), SLC22A18
and KCNQ1OT1 which were expressed biallelically. An apparent
allelic bias was present in some of the samples for NAP1L5 (Fig. 2),
although without parental DNA we cannot establish which allele
was preferentially expressed. This bias was not present upon
separation of the whole blood into individual fractions. Strand-
specific RT-PCR of KCNQ1OT1 transcripts was carried out to
ensure no unspliced nascent KCNQ1 transcripts were amplified,
and also showed KCNQ1OT1 to be biallelic (Fig. S2). Group 3 is
distinct from Group 1 as the biallelic expression of the genes in
Group 3 was unexpected given their monoallelic expression status
in other tissues. Interestingly, of the ten genes that were more
highly expressed in blood than fetal tissues (Fig. S1), only SNRPN
remained monoallelic (IPW and TP73 could not be analysed as
they were undetectable by nqRT-PCR).
PBL are a circulating cell population, and are therefore not in
contact with a static cell niche. To evaluate changes in gene
expression from the time of cell release into the circulation, we also
analysed adult human bone marrow samples (n = 6), as the origin
Table 1. Summary of expression levels and allele specificity in human PBL.
Locus/Cluster
Transcripts in
cluster & accession UCSC SNP
Methylated
DMR*
P of
O** MeanDCT
QPCR
relative exp
RT
PCR
Allelic
Expression
4q22 NAP1L5 NAP1L5: NM_153757 rs710834 Prom MATG Pat 5.6 Highest 33 9/9 B
6q24 PLAGL1 PLAGL1 Isoform 2:
NM_001080951
rs9373409 Prom MATG B 12.6 Highest 45 3/3 B
6q25 IGF2R IGF2R: NM_000876 rs614754 Mat 2.3 Highest 35 1/1 B
7q21 PEG10 PEG10 NM_015068 rs13073 Prom MATG Pat 9.1 Pl, Li, Br 36 4/4 M
7q32 MEST MEST Iso 2 NM_177524 Pat 7.6 Br 35 8/9 B; 1/9 M
10q26 INPP5F_V2: NR_003252 rs3188055 Prom MATG Pat 16.0 Pl, Li, Br 40 8/11 M; 3/11 B
11p15 KCNQ1 SLC22A18 NM_183233 rs1048046/7 KvDMR MATG Mat 8.2 Highest 40 5/5 B
CDKN1C NM_000076 PAPA RPT Mat 7.5 Pl U U
KCNQ1OT1 NM_000128 rs231357/9 Pat 5.4 Highest 40 6/6 B
KCNQ1 NM_000218 rs1057128 Mat 5.0 Highest 38 3/3 B
11p15 IGF2/H19 IGF2 NM_000612 rs680 DMR0,1,2 PATS
PATG PATS
Pat 11.8 Pl, Li, Br, BM 40 20/20 M
15q11
SNURF/SNRPN
NDN NM_002487 rs2192206 Prom MAT? Pat 13.6 Pl, Li, Br, BM 40 3/3 M
SNRPN NM_022806 rs705 Prom MATG Pat 2.4 Highest 40 3/3 M
IPW NR_023915 rs691 Pat 6.2 Br, Li 35 5/5M
20q13 GNAS GNAS NM_000516 rs7121 1A Prom MATG Mat 0.3 Highest 33 13/13 B
Exon 1A X56009 1A Prom MATG Pat 6.7 Pl 40 7/7 M
Cluster/Locus - the cluster where the transcripts analysed (Transcripts in cluster & accession) are located. UCSC SNP annotation - the expressed polymorphism
analysed for the allelic expression data.Methylated DMR - the differentially methylated regions associated with each cluster and the parental origin of the methylated
allele,
*DMR identified in previously published work from other laboratories (see Table S1 for references); Prom = promoter; MAT/PAT = maternal/paternal allele methylated;
G/S = DMR established in the germline/post fertilisation. P of O – the parental origin of the expressed allele
**established in previously published work from other laboratories – extensive references available for each gene @ http://igc.otago.ac.nz/table.html. Mat/Pat =
maternal/paternal allele expressed. Mean DCT 1d.p. - the average of DCT values of PCL samples A and B for each gene to one decimal place. Generally DCT values
above 9 ( = 2‘-dCT of 0.001) could be deteced by non-quantitative (nq) RT-PCR. U = below nq RT-PCR detection. The separate Q-PCR expression data from each
individual are shown in Table S1. QPCR relative exp - the expression of these genes relative to the other tissues examined in Fig. S1. Pl = Placenta; Li = Liver; Br =
brain; BM = bone marrow. Genes which were most highly expressed in PBL compared to fetal tissues are denoted ‘Highest’; in all cases except for SNRPN, these genes
are biallelically expressed. RT-PCR - the number of nq RT-PCR cycles required to generate a product that could be sequenced reliably. The fractions in the Allelic
Expression column indicate the number of biallelic or monoallelic samples there were of the total that were heterozygous (i.e. informative) for each SNP. The number
of informative samples represents the total found following genotyping of 50 individuals., M/B = mono/biallelic. The complete data set and references, (data from
humans and mice) can be found in Table S1.
doi:10.1371/journal.pone.0013556.t001
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of the predominant myeloid cell population in peripheral blood
(Fig. S1). Although displaying the same pattern of expression
where GNAS, SNRPN and IGF2R are most highly expressed, bone
marrow has a lower level of expression of imprinted genes
compared to PBL (Tables 1 and S1).
Analysis of allelic expression in separated leukocyte
populations
Both imprinted and non-imprinted monoallelic expression can
be cell-type specific within certain organs [20,21]. To ensure that a
sub-population of biallelically expressing cells was not masking
monoallelic expression from other blood lineages we isolated the
three predominant cell types found in the PBL population. PBL
samples from three informative individuals were analysed with
respect to the allelic expression of NAPIL5, PLAGL1 Isoform 1,
PLAGL1 Isoform 2, MEST Isoform 2, KCNQ1OT1, SLC22A18,
IGF2, SNRPN and NDN in CD19+ B-lymphocytes (5%), CD3+ T-
lymphocytes (25%) and CD15+ myeloid cells (50–70%). The
biallelic/monoallelic expression pattern of the genes was identical
for each cell type and for the total PBL population previously
analysed (Fig. 2 and Table 2).
Analysis of differential methylation at imprinting control
regions
Monoallelic expression of imprinted genes is controlled by
differential methylation at imprinting control regions, (ICRs). We
therefore investigated a number of the differentially methylated
regions (DMRs) known to be associated with the imprinted genes
analysed in this study. Each of the 15 chosen DMRs were analysed
by combined bisulphite and restriction analysis (CoBRA) in two
individuals and were all found to be maintained (Fig. 3).
To quantify DMR methylation we also analysed nine DMRs,
and one non-DMR, by pyrosequencing in 12 PBL samples. The
12 individuals analysed included those used for quantification of
gene expression (PBLA and B) and demonstrated that neither were
outliers, shown in Fig. S3. Threshold levels of methylation in these
samples were set as described previously (20). This allowed analysis
of between three and 11 CpGs per region, where CoBRA permits
only one or two. Average methylation across the region for the 12
samples was calculated for each DMR and is displayed in Fig. 4.
Individual data for each CpG dinucleotide are shown for KvDMR
(b), NESP promoter (c), H19 DMD (d) and the non-DMR (e) in
Fig. 4, and the remaining DMRs in Fig. S4. In PBL DNA, each of
the DMRs analysed revealed intermediate levels of methylation,
ranging between 35 and 50%, which is consistent with methylation
levels if only one parental allele is methylated. Methylation at a
control region which is not a DMR in blood, and is
hypomethylated, is shown with median methylation levels of
10%. An adult brain DNA sample was analysed as a reference
tissue sample and methylation levels fell within the interquartile
ranges of the methylation detected in PBL, with the exception of
IGF2 DMR0 and KvDMR. The latter DMR in brain had higher
methylation levels than blood, but these were still within normal
levels as expected for an imprinted gene. Similarly, IGF2 DMR0 in
brain was less methylated compared to PBL but still within the
normal threshold levels (Fig. 4). These results together demon-
strate the presence of the methylation mark as would be expected
Figure 2. Allelic expression analysis of whole blood and immune-separated leukocyte fractions. Exemplar sequence traces of RT-PCR
amplicons represent the genotypes and expression at specific SNPs for (i) NAP1L5 and (ii) SNRPN, in whole blood peripheral leukocytes, and then in
each separated lineage component. It is clear that the lack of imprinting for NAP1L5 seen in the fractions containing unseparated PBL, or indeed the
maintained imprinting of SNRPN, is not due to either allele switching or the masking of underlying imprinted expression in a cell subtype, at least for
the cell populations examined here. Table 2 lists the complete data set of allelic expression of imprinted genes in separated PBL cell populations from
three individuals.
doi:10.1371/journal.pone.0013556.g002
Imprinting in Human Blood
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for imprinted monoallelic expression. However, biallelic expres-
sion is observed for two of these regions in PBL.
In silico analysis of a gene expression histone signature
To investigate the possibility that histone modifications could be
responsible for the regulation of expression at the promoters of
imprinted genes with maintained DMRs, we consulted the online
human ChIP database to assess the levels of histone methylation
and acetylation (http://dir.nhlbi.nih.gov/papers/lmi/epigenomes/
hgtcell.html). For almost all of the imprinted genes that we found to
be expressed in PBL, a histone signature comprising 17 modifica-
tions was present. For genes where we could not detect expression,
the signature was partially or completely absent (Fig. S5). Of the
imprinted genes analysed, two, MEST and PLAGL1, are known to
have alternatively expressed, biallelic promoters that are active in
PBL only. Expression in all other tissues is imprinted and originates
from the respective DMR [22,23]. The histone modification
signatures weremost pronounced at the PBL-specific transcriptional
start sites of MEST and PLAGL1. These PBL-specific promoters
were associated with the full complement of modifications
Table 2. Expression and allele specificity in separated myeloid, T and B lymphocyte fractions.
Gene n Whole PBL Myeloid Cells T-Lymphocytes B-Lymphocytes
NAP1L5 1 Biallelic Biallelic Biallelic Biallelic
PLAGL1 Iso1 1 NE NE Monoallelic Monoallelic
PLAGL1 Iso2 1 Biallelic Biallelic Biallelic Biallelic
MEST Iso2 1 Biallelic Biallelic NE Biallelic
KCNQ1OT1 2 Biallelic Biallelic Biallelic Biallelic
SLC22A18 2 Biallelic Biallelic Biallelic Biallelic
IGF2 1 Monoallelic NE Monoallelic NE
SNRPN 1 Monoallelic Monoallelic Monoallelic Monoallelic
NDN 2 Monoallelic Monoallelic Monoallelic Monoallelic
M, monoallelic; B, biallelic; NE, not expressed. Three informative individuals were selected, and n numbers are the number of individuals informative for SNP in each
respective gene. Expression patterns varied slightly but allele specificity was identical between sub-populations.
doi:10.1371/journal.pone.0013556.t002
Figure 3. Analysis of differential methylation at imprinted loci using combined bisulphite and restriction analysis (CoBRA).
Imprinting control regions at each locus were analysed in two adult PBL samples (PBLC (1) and PBLD (2)) and the presence of a DMR verified by the
presence of both undigested and digested amplicons (restriction enzymes used in each case are given in Table S4). Undigested products are
representative of unmethylated DNA alleles, where the restriction site is lost through C conversion to T. Digested products indicate the presence of
an unmodified CpG dinucleotide in the recognition site, representative of methylated DNA. All differentially methylated regions analysed were
maintained, crucially including those ICRs for genes which in our hands were expressed biallelically (b, d, e and o). The DMRs analysed represent both
those which are germline (a - e, g, j, l - m, o - p) and somatic (f, h, k and n) in origin, and those methylated on the maternal (a - f, l, m, o and p) and
paternal (g, h, j, k and n) alleles.
doi:10.1371/journal.pone.0013556.g003
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associated with high expression, whereas the DMR associated
promoters were not.
Discussion
In this study we investigate the use of adult human blood as a
tissue to detect expression and imprinting status of a number of
known imprinted genes. Of the 36 tested only six were detectably
imprinted, with the others not proving to be reliable for LOI
studies. Principally this was due to a very low level or complete
lack of expression, while others were either biallelic or variably
expressed in different individuals, despite maintaining differential
methylation at respective imprinting control regions. These
biallelic expression data were largely unexpected given the
monoallelic status of these genes in the human fetus [17,24].
Previous findings describing extremely low but monoallelic IGF2
expression and robust monoallelic expression of SNRPN in PBL
were supported [25,26].
In vivo loss of ICR differential methylation in mice results in a
loss of imprinting [27]. In humans, hypo- or hypermethylation of
individual loci results in either a loss of, or biallelic, gene
expression [28,29]. However, in adult PBL, we show that a lack
of imprinting does not correlate with a loss of differential ICR
methylation. Discordant methylation and expected imprinted
expression at the IGF2-H19 locus has been reported in many
cancer studies [30–32]. Our analysis contained both germline
DMRs, such as the H19 ICR and somatic DMRs which acquire
methylation after fertilisation, such as IGF2 DMR0. Somatic
DMRs are more variable in their methylation levels and are also
likely to be tissue specific. For example, it has been shown that
hypomethylation of DMR0 increases with age and does not result
in loss of imprinting of IGF2 in normal individuals [26].
Figure 4. Quantification of DNAmethylation at differentially methylated regions (DMRs). (a) Methylation was quantified in the peripheral
blood of 12 individuals using a standard pyrosequencing assay for 9 different DMRs and one non-DMR, a region upstream of the GRB10 gene (18)
Average methylation across the DMR regions for all CpGs was calculated. Methylation levels of DMRs in PBL samples shown in red, (n = 12) and brain
as black crosses (n = 1). Box plots represent medians and interquartile ranges and max and min values. Data for individual CpGs across the region are
illustrated for (b) KvDMR, (c) GNAS NESP Promoter (d) H19 DMR and (e) the non-DMR in PBL. Methylation levels consistent with differential
methylation were reported for all nine DMRs examined. In (b), the KvDMR and (c) the NESP promoter, several expressed transcripts in these regions
were biallelic. As would be expected, all transcripts associated with the H19 DMR (d) i.e. IGF2 and H19 were expressed monoallelically. The non-DMR
in PBL (e) was hypomethylated in this tissue and exhibited a tissue-specific methylation increase in brain. CoBRA and pyrosequencing primers were
different but colocalised: amplicons were within 50 bp of each other for SNRPN; within 1 kb for MEG3 prom, 500 bp for KvDMR, 100 bp for PLAGL1
100 bp, overlapped for NESP prom, 100 bp for H19 ICR and 50 bp for IGF2 DMR0. Each assay included between three and 11 CpGs and remaining
individual data for each CpG in all regions are shown in Fig. S4. Pyro Q-CpG Software (Biotage, Uppsala, Sweden) was used to calculate the ratio of
converted C’s (T’s) to unconverted C’s at each CpG, this is expressed this as a percentage methylation.
doi:10.1371/journal.pone.0013556.g004
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Methylation of the somatic DMR0 is thought to be controlled by,
and indicative of, the methylation state of the H19 ICR [33].
These observations are suggestive of an uncoupling of
methylation and imprinted expression, indicating that an epige-
netic mechanism other than DNA methylation may be involved.
This has been observed previously in stem cells [34] and in normal
tissues, for example Igf2/IGF2 and H19 are biallelic in certain
regions of the brain despite maintenance of the H19 DMD [35,36]
and also Kcnq1 expression in mice becomes biallelic after birth
despite maintenance of the KvDMR [37]. Recently, a histone
signature comprising 17 modifications has been shown to mark the
transcriptional start sites of highly expressed genes in T
lymphocytes [38]. This histone modification signature correlated
almost universally with whether the gene was expressed in PBL or
not. Of particular interest are MEST and PLAGL1, which have
alternatively expressed, biallelic promoters that are active in PBL
only, whereas expression in all other tissues is imprinted and
originates from the respective DMR [22,23]. This is strongly
associated with histone allocation since the PBL-specific transcrip-
tional start sites of MEST and PLAGL1 are associated with the full
complement of modifications associated with high expression,
whereas they are absent at the DMR associated promoters of these
two genes.
The KCNQ1OT1 transcript is paternally expressed, and biallelic
expression of this transcript is caused by a loss of maternal
methylation at the KvDMR, as occurs in BWS. This usually leads
to silencing of the other imprinted genes in this domain
(SLC22A18, PHLDA2, CDKN1C, and KCNQ1) [39]. We find
KCNQ1OT1 to be universally biallelic amongst PBL samples,
however, surprisingly neither SLC22A18, CDKN1C nor KCNQ1
were silenced, and SLC22A18 and KCNQ1 were found to also be
biallelic. In addition, methylation at the KvDMR was still within
normal ranges for a DMR. Analysis of KCNQ1OT1 and SLC22A18
allelic expression in the separated T-lymphocyte, B-lymphocyte
and myeloid cell sub-populations within PBL found the same
biallelic expression pattern in each cell type. Recently the
KCNQ1OT1 ncRNA is was shown to be dispensable for silencing
at this locus, specifically in the mouse embryo, dependent only on
DNA methylation at the KvDMR, and possibly subsequent CTCF
binding [40]. We suggest that this mechanism also occurs in
human adult PBL, explaining the continued expression of KCNQ1
and CDKN1C despite biallelic KCNQ1OT1.
In a highly proliferative and circulatory cell type such as
leukocytes it may be favourable to down-regulate imprinted gene
expression, as we observe, either through alternative promoter
usage or another epigenetic process i.e. enrichment of repressive
histone modifications. The disruption of imprinted gene DMRs
has been linked with diseases such as cancer and syndromic
imprinting disorders [6,41]. Our results do not contradict this, as
we find no changes in DMR methylation in the PBL of healthy
people when compared to another tissue. Subsequently, changes in
methylation at multiple imprinted loci in leukocyte DNA, as
observed in some cases of BWS and SRS, remain useful for
diagnosis of imprinting disorders [42].
It has been suggested that biallelic expression of imprinted genes
such as IGF2 may be a useful predictive marker for risk of
colorectal cancer development, even in other, unaffected tissues
such as blood [6]. The monoallelic status in normal adult blood of
six of the imprinted genes we analysed potentiates their use as a
marker, however, of these only IGF2 has been linked to
tumorigenesis. The remaining 30 imprinted genes were either
biallelic or below detectable levels in adult peripheral blood
leukocytes. Here we demonstrate that many imprinted genes are
not highly expressed in blood, and those that are expressed are
mostly biallelic. Therefore, a lack of imprinting in adult human
blood is both common, normal and in most cases unlikely to
provide a useful marker for disease.
URLs
Imprinted genes: http://igc.otago.ac.nz/
Histone Methylation: http://dir.nhlbi.nih.gov/papers/lmi/
epigenomes/hgtcell.html
Supporting Information
Figure S1 Comparison of imprinted gene (in alphabetical order)
expression in fetal tissues, adult PBL and bone marrow. The
expression of genes in PBL was quantitatively compared to that in
the following tissues: (in order of graph, from left to right) adult
bone marrow (very pale grey), fetal brain (pale grey), fetal liver
fetal (grey), fetal placenta (dark grey) and adult peripheral blood
leukocyte samples A and B (PBLA/B in red). Fetal samples were a
mix from two fetuses (Moore fetal tissue cohort) and the adult bone
marrow was from a mix of six individuals who had died suddenly
(Clontech, CA). The graphs are plotted as in Figure 1, with
y = log2-deltaCt. This calculation makes the expression level of
GAPDH equal to 1.
Found at: doi:10.1371/journal.pone.0013556.s001 (0.06 MB
PDF)
Figure S2 Strand specific RT-PCR of KCNQ1OT1 cDNA was
created as before except random primers were not included and
reverse transcriptase was primed using B-ACTIN and
KCNQ1OT1 reverse primers. 2 ug RNA was converted to cDNA
using MMLV reverse transcriptase and RT- samples created in
parallel with MMLV RT omitted. B-ACTIN RT-PCR for 30
cycles confirmed successful cDNA synthesis without DNA
contamination. KCNQ1OT1 RTPCR was carried out for samples
informative for the rs231357 A/T polymorphism in KCNQ1OT1
(PBL6, PBL7 and PBL13) using 2 ul of RT+ and RT- for each
sample. RT-PCR was carried out for 40 cycles and the amplicons
sequenced in the forwards direction. In each case, KCNQ1OT1
was found to be biallelically expressed.
Found at: doi:10.1371/journal.pone.0013556.s002 (0.06 MB
PDF)
Figure S3 Quantitative measurement of methylation at each
DMRs in the two individuals for which expression levels were
analysed The two individuals for which we analysed expression of
imprinted genes were included in the 12 individuals for which
pyrosequencing methylation analysis were carried out on. The
max and min bars in Fig. 4 and S4 demonstrate the presence of
outliers in the sample, so to check whether these two samples were
those outliers - and thus not representative for expression analysis,
we created box plots including these samples only (PBLA in Blue,
PBLB in Red). Both samples follwed the pattern of the analysis for
the pool of 12, there were no large variations between the two
samples. There was insufficient DNA in PBL2 to allow analysis of
the PLAGL1 DMR so no data point is present for this sample.
Found at: doi:10.1371/journal.pone.0013556.s003 (0.27 MB
PDF)
Figure S4 Quantitative measurement of methylation at individ-
ual CpGs of analysed DMRs A: DIRAS3. B: PLAGL1. C: IGF2
DMR0. D: H19 ICR. E: KvDMR. F: GTL2 Promoter. G:
SNRPN. H: MCTS2. I: NESP Promoter J: Non DMR. To
quantify DMR methylation we analysed 10 DMRs by pyrose-
quencing in 12 PBL samples, and compared them to fetal brain.
Pyrosequencing allowed analysis of between three and 11 CpGs
per region, with methylation levels shown as individual box plots
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for the PBL samples, and a black cross for the fetal brain sample.
Average methylation between the 12 PBL samples is shown as a
box plot. Each of the DMRs analysed revealed the expected
methylation level for a DMR in PBL and in brain. The non DMR
region in (J) was hypomethyated in PBL compared to brain.
Found at: doi:10.1371/journal.pone.0013556.s004 (0.09 MB
PDF)
Figure S5 Histone modification expression signatures Using the
Human March 2006 hg18, assembly (NCBI Build 36.1), high-
resolution maps for the genome-wide distribution have been
generated (Barski et al., 2007; Wang et al., 2008). Adding each of
17 histone modification tracks found to be associated with expression
to the UCSC browser we were able to show that in T-lymphocytes,
for genes we find to be expressed in PBL, almost all of the gene
promoters are associated with the signature (http://dir.nhlbi.nih.
gov/papers/lmi/epigenomes/hgtcell.html),. The signature was not
present at promoters of genes which were not expressed. The
examples of (i) SNRPN; an expressed gene, and (ii) the two MEST
isoforms are shown. Each MEST isoform originates from a separate
promoter, one of which is active in blood, the other not.
Found at: doi:10.1371/journal.pone.0013556.s005 (0.03 MB
PDF)
Table S1 Complete list of QRT-PCR, non quantitative PCR
and allelic expression analysis data for all imprinted genes
analysed. Prom, promoter; MAT/PAT, maternally/paternally
methylated DMR; G/S, DMR established in the germline/post
fertilisation; Mat/Pat, maternal/paternal allele expressed; BT,
below QPCR detection, i.e. linear amplification was not reached
by Threshold, equivalent to a 2-dCt of less than 1x10-12; U, below
non-quantitative RT-PCR detection up to 45 cycles; M/B, mono/
biallelic; For QPCR: Pl, Placenta; Li, Liver; Br, brain; BM, bone
marrow; ND, not done, ‘highest’ indicates that expression relative
to the other tissues was highest in PBL. dCtB-dCtA, difference
between the dCts of PBLA and PBLB. 2-dCtPBL A/B (3 s.f.),
values are shown to 3 significant figures. The fractions in the
‘Allelic Expression’ column indicate the number of biallelic or
monoallelic samples there were of the total that were heterozygous
(i.e. informative) for each SNP. The number of informative
samples represents the total found following genotyping of 50
individuals. *Methylated allele of DMR identified in previously
published work, references as shown. ** Parent-of-origin of
expression established in previously published work from other
laboratories - the various references for imprinted expression and
parent-of origin for each gene may be located at http://igc.otago.
ac.nz/table.html.
Found at: doi:10.1371/journal.pone.0013556.s006 (0.16 MB
DOC)
Table S2 Quantitative RT-PCR primers for analysis of gene
expression levels. PCR carried out using cDNA template, i.e. post
reverse transcription reaction (RT-PCR). Gene transcripts,
primers and amplicon size are shown. Each reaction was carried
out with a Tm of 60uC for 40 cycles. DM = primers designed by
Dave Monk, JF = primers designed by Jennifer Frost.
Found at: doi:10.1371/journal.pone.0013556.s007 (0.09 MB
DOC)
Table S3 Allele specific assays for gene expression - detailing
SNPs, transcripts, primers and amplicon size. Genotyping, PCR
using genomic DNA template; RT, PCR using cDNA template,
i.e. post reverse transcription reaction; D, direction; Tm,
annealing temperature; JF, primers designed by Jennifer Frost.
Found at: doi:10.1371/journal.pone.0013556.s008 (0.14 MB
DOC)
Table S4 Bisulphite PCR primers for analysis of differential
methylation at imprinted differentially methylated regions.
Amplicons were subjected to Combined Bisulphite and Restriction
(CoBRA) assays and bisulphite sequencing. Primers are specific for
bisulphite converted DNA. Where CpG dinucleotides appear in
the primer, 1:1 primer mixes are prepared with either a C or a T
base in the forwards direction (YG) and a G or an A base in the
reverse (CR). Bisulphite PCR was carried out using Tm of 53 uC,
except for KvDMR where the Tm was 50 uC, and all for 45
Cycles. The size/enzyme column indicates the restriction
endonuclease used in the CoBRA assays. DM = primers designed
by Dave Monk, JF = primers designed by Jennifer Frost.
Found at: doi:10.1371/journal.pone.0013556.s009 (0.09 MB
DOC)
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